ISRG Filing
4Filing Date: Jun 12, 2026

INTUITIVE SURGICAL INC (ISRG) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0002010300-26-000021open_in_new
Total Value$19.8K
Trades2
Insiders1

Transaction Details

Brosius Mark
EVP & Chief Mfg and Supply Cha·Direct
Sell · Dispose
Common Stock
Shares-25
Price$414.13
Total Value$10.4K
Shares Owned After1.41K
Transaction DateJun 12, 2026
10b5-1
Footnotes ▸

The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.

Brosius Mark
EVP & Chief Mfg and Supply Cha·Direct
Sell · Dispose
Common Stock
Shares-23
Price$412.16
Total Value$9.5K
Shares Owned After1.43K
Transaction DateJun 11, 2026
10b5-1
Footnotes ▸

The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.

Post-Transaction Holdings

Brosius Mark
SecuritySharesChange
Common Stock1.41K-48 (-3.30%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-11 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: INTUITIVE SURGICAL INC (ISRG) CIK: 0001035267 --- Reporting Owner --- Name: Brosius Mark CIK: 0002010300 Role: Officer (EVP & Chief Mfg and Supply Cha) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-11 | Code: S (Open market sale) Shares: -23 | Price: $412.16 Total Value: $9,479.68 Shares Owned After: 1,431 | Ownership: D (Direct) Footnotes: [F1] The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. [Transaction #2] Security: Common Stock Date: 2026-06-12 | Code: S (Open market sale) Shares: -25 | Price: $414.13 Total Value: $10,353.25 Shares Owned After: 1,406 | Ownership: D (Direct) Footnotes: [F1] The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. --- Footnotes (Complete Index) --- F1: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. --- Signature --- /s/ By: Stephanie Lim-Ignacio For: Brosius, Mark (2026-06-12)

keid AI analysis is for reference only and does not constitute investment advice.